Leximed
ActiveSummary
Leximed has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €49,936 and a net result of €36,469. Equity is growing by about 149% per year across the filed financial years. Its solvency ranks better than 71% of 20,643 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Leximed was incorporated on 14 February 2023 as a private limited company by one natural person, with a starting capital of €3,000.12 Since 2024 the company has been called Leximed.3 The registered office was moved to Schoten in 2024.3 Since 2023, MALDAGUE Alexia Christine Denise Walter has served as director of the company.2 Total assets rose from €19,405 in 2023 to €61,584 in 2025.4
Acts, filings and financial milestones
21-11
Gazette deed
Registered office · NameName change · Registered-office move · Power of attorney4 facts ▸
- General meeting, 23-10-2024
- Name change, Leximed
- Registered-office move, 2900 Schoten,Struikenlei 16
- Power of attorney, Bart Van Tulden
16-02
Gazette deed
IncorporationAppointment: MALDAGUE Alexia Christine Denise Walter (director) · Founder · Founding capital8 facts ▸
- Incorporation, 09-02-2023
- Founder, MALDAGUE Alexia Christine Denise Walter (oprichter aandeelhouder)
- Founding capital, €3,000
- Shareholding, 09-02-2023, 100
- Bank account, “KBC Bank”, 3000 (deed in Dutch)
- Other provision, “bevestiging deponering”, 3000 (deed in Dutch)
- Director appointment, MALDAGUE Alexia Christine Denise Walter (director (not named in the articles))
- Pre-incorporation commitments, “takeover, alle verbintenissen,verplichtingen en activiteiten in naam en voor rekening van vennootschap in oprichting” (deed in Dutch)